Cambridge, United Kingdom

William Rameschandra Krishna Esmieu

This inventor holds 1 USPTO granted patent. Top assignee: Usher III Initiative, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Rameschandra Krishna Esmieu. Retrieved from https://idiyas.com/inventor/william-rameschandra-krishna-esmieu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by William Rameschandra Krishna Esmieu

Introduction

William Rameschandra Krishna Esmieu is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of medical science, particularly focusing on retinal degenerative diseases and associated hearing loss. With a patent to his name, Esmieu stands out as an innovator dedicated to improving the quality of life for individuals facing these challenging health issues.

Latest Patents

Esmeiu holds a patent for his work titled "Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndrome." This innovative patent encompasses compounds, compositions, and methods designed to treat a variety of retinal degenerative diseases, including retinitis pigmentosa, Leber's congenital Amaurosis, syndromic retinal degenerations, age-related macular degeneration, and hearing loss associated with Usher Syndrome. His research offers promising avenues for addressing these critical health challenges.

Career Highlights

Esmeiu's career is marked by his role with the Usher III Initiative, Inc., where he continues to work on groundbreaking research aimed at combatting retinal degeneration. His dedication to understanding and addressing the complexities of retinal and auditory health has made him a valuable asset to the organization.

Collaborations

Throughout his career, Esmieu has collaborated with notable colleagues, including Roland Werner Bürli and Christopher James Lock. These collaborations have allowed for the exchange of ideas and expertise, further enhancing the development and implementation of innovative solutions in the realm of retinal degenerative treatments.

Conclusion

In summary, William Rameschandra Krishna Esmieu exemplifies the spirit of innovation in medical research. His patent on treating retinal degenerative diseases and hearing loss showcases his commitment to advancing healthcare solutions. With continued collaboration and dedication, Esmieu’s contributions may lead to significant advancements in the treatment of these challenging conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…